As of January 22, 2025, Sino Biopharmaceutical (1177.HK) has a market cap of $6.77 billion USD. According to our data, Sino Biopharmaceutical is ranked No.2207 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $6.77 B |
-9.94%
|
Dec 31, 2024 | $7.52 B |
-5.31%
|
Dec 29, 2023 | $7.94 B |
-22.28%
|
Dec 30, 2022 | $10.22 B |
-14.19%
|
Dec 31, 2021 | $11.91 B |
-27.28%
|
Dec 31, 2020 | $16.38 B |
4.59%
|
Dec 31, 2019 | $15.66 B |
112.66%
|
Dec 31, 2018 | $7.36 B |
-43.82%
|
Dec 29, 2017 | $13.11 B |
156.52%
|
Dec 30, 2016 | $5.11 B |
-21.75%
|
Dec 31, 2015 | $6.53 B |
51.58%
|
Dec 31, 2014 | $4.31 B |
15.39%
|
Dec 31, 2013 | $3.73 B |
67.83%
|
Dec 31, 2012 | $2.22 B |
62.55%
|
Dec 30, 2011 | $1.37 B |
-17.48%
|
Dec 31, 2010 | $1.66 B |
18.59%
|
Dec 31, 2009 | $1.40 B |
386.05%
|
Dec 31, 2008 | $0.29 B |
-25.24%
|
Dec 31, 2007 | $0.38 B |
63.43%
|
Dec 29, 2006 | $0.24 B |
-39.92%
|
Dec 30, 2005 | $0.39 B |
60.84%
|
Dec 31, 2004 | $0.24 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
Market Cap | = | 1177.HK Stock Price | * | 1177.HK Shares Outstanding |
= | $0.37 | * | 18.18 B | |
= | $6.77 B |